Subscribe to MDT Magazine News

Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards

April 6, 2011 11:32 am | by Bio-Medicine.Org | Comments

MADISON, N.J., April 6, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best...


High levels of toxic compounds found on coasts of West Africa

April 6, 2011 9:40 am | by EurekAlert | Comments

(FECYT - Spanish Foundation for Science and Technology) An international team of scientists has found very high levels of polychlorinated biphenyls (PCBs) along the coasts of West Africa. Production of these extremely toxic compounds has been banned in Europe and the United States...

Texas Independent Drugstore Lobby (Continues) Putting Profits Ahead of Patients

April 6, 2011 9:38 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 6, 2011 /PRNewswire-USNewswire/ -- To help reduce state Medicaid spending and save taxpayers $84 million, Governor Rick Perry (R) has proposed that the program's prescription drug benefits be operated more like those in the private sector that are more affordable and...


Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

LabCorp in $85.4M deal for DNA testing company

April 6, 2011 8:45 am | by The Associated Press | Comments

Laboratory Corp. of America Holdings said Wednesday it agreed to acquire all shares of DNA and paternity testing services company Orchid Cellmark Inc. for $85.4 million, or $2.80 per share.LabCorp, a clinical lab services company based in Burlington, N.C., said it expects the deal to close...

Neural guidance gene regulates liver development

April 6, 2011 8:39 am | by EurekAlert | Comments

(Helmholtz Association of German Research Centres) Scientists of the Max Delbrueck Center in Berlin have demonstrated for the first time that a gene regulating neuronal cell migration during embryogenesis also plays a role in liver development. Using zebrafish as a model organism,...

Most recent mammography recommendations confuse public

April 6, 2011 8:39 am | by EurekAlert | Comments

(Elsevier Health Sciences) When the USPSTF released its recommendations on mammography screenings for US women on Nov. 16, 2009, there was immediate and considerable controversy. In a study published in the American Journal of Preventive Medicine, investigators report that these...

PMA Final Decisions for February 2011

April 6, 2011 8:38 am | by U.S. Food & Drug Administration | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for February 2011.


Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010

April 6, 2011 8:37 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- cites in its newly published " Medical Imaging Markets" report that global spending on medical imaging equipment exceeded $21 billion in 2010. For more information, visit:...


United Nations Urged to Ban Mercury in Vaccines

April 6, 2011 8:36 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- CoMeD – While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD), a Maryland-based, non-profit organization, is urging the...

KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK, April 6, 2011 /- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to...


MIT's Koch Institute to use Roche LightCycler 480 System to Help Advance Cancer Research

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, April 6,  2011 /- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler ® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of...


Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes

April 6, 2011 8:34 am | by Bio-Medicine.Org | Comments

MALIBU, Calif., April 6, 2011 /- Cliffside Malibu, one of America's leading drug and alcohol treatment centers, is strongly urging its patients who are currently taking antidepressants not to stop, despite a new study and subsequent media reports that such drugs could raise the risk of...


An international study in China finds strawberries may slow precancerous growth in the esophagus

April 6, 2011 7:38 am | by EurekAlert | Comments

(Ohio State University Medical Center) Eating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer...

Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions

April 6, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

The most common severe reactions include enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, and endocrinopathy.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.